BioSpace News Archive

United Health Products, Inc. provided an update on the company’s FDA Premarket Approval application process.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that Emil D. Kakkis, M.D., Ph.D., the company’s chief executive officer and president, will participate in a fireside at the upcoming Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, at 3:20 p.m. PT.

Tractus Vascular, LLC today announced 510(k) clearance of the Tunnel™ Crossing Catheter (Tunnel™ CC).

Both Companies Anticipates Approval to Launch of Human Clinical Trials

RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research grant from the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health.

EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies, announced the appointment of Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer.

GE HealthCare Technologies Inc. announced the pricing of the previously announced secondary underwritten public offering of 25,000,000 shares of its common stock at a public offering price of $78.00 per share.

BioArctic AB’s partner Eisai announced that Eisai has submitted a marketing authorization application for lecanemab, an investigational anti-amyloid beta protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2] with confirmed amyloid pathology in the brain, to the Ministry of Food and Drug Safety in South Korea.

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced that it will present new data at the EASL Congress which will take place on June 21-24, 2023 in Vienna, Austria.

4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company) today announced positive interim clinical data from the 4D-710 Phase 1/2 AEROW clinical trial for the treatment of cystic fibrosis lung disease.